Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Perrigo
company
About
Providing the world with quality, affordable healthcare products.
- 10001 - max
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $2.60B
- Industries
- Biotechnology,Manufacturing,Pharmaceutical
- Founded date
- Jan 1, 1887
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.60B
Perrigo has raised a total of
$2.60B
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2022 | Post-IPO Debt | $2.60B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Perrigo is funded by 1 investors.
JP Morgan Chase
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
JP Morgan Chase
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
